Sarcoma Diagnosis and Treatment Guidelines

Initial Diagnostic Approach

The European Society for Medical Oncology recommends that all suspected sarcomas must be managed at a specialized sarcoma reference center with multidisciplinary team (MDT) involvement from the outset, and biopsy should be performed under the supervision of the treating surgical team or dedicated interventional radiologist 1, 2
Core needle biopsy (multiple cores, not fine-needle aspiration) is the preferred diagnostic method, performed under imaging guidance (ultrasound, CT, or X-ray), as recommended by the European Society for Medical Oncology 3, 2, 4

The European Society for Medical Oncology states that histological grading using the FNCLCC (Fédération Nationale des Centres de Lutte Contre le Cancer) system is mandatory, which scores differentiation, necrosis, and mitotic count to determine grades 1-3 5, 6, 4
Molecular pathology testing should be performed when diagnosis is doubtful, clinical presentation is unusual, or it has prognostic/predictive relevance, as recommended by the European Society for Medical Oncology 5, 6

The European Society for Medical Oncology recommends that chest CT scan is mandatory to detect pulmonary metastases, as lungs are the most common metastatic site 5, 6, 4
MRI of the entire affected bone/extremity with adjacent joints is the best modality for local staging, as recommended by the European Society for Medical Oncology 1, 7, 3

The American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC) state that the current staging system emphasizes histological grade as the primary determinant, combined with tumor size, depth, and presence of metastases 5, 6
Histological grade is the most important prognostic factor, followed by tumor size, tumor depth, presence of metastases, and anatomic site, as recommended by the AJCC and UICC 5, 6

The National Comprehensive Cancer Network (NCCN) recommends that all diagnostic and treatment decisions must be discussed at a specialized sarcoma MDT meeting before any definitive intervention 1, 2, 4, 8
Wide excision with negative margins (R0) is standard for localized soft tissue sarcoma, performed by a surgeon specifically trained in sarcoma treatment, as recommended by the NCCN 5, 2, 6, 4
Radiation therapy (50-60 Gy) is standard for high-grade, deep tumors >5 cm following wide excision, as recommended by the NCCN 5, 6, 8

The European Society for Medical Oncology warns that never performing inadvertent excision without preoperative diagnosis contaminates the surgical field and worsens outcomes 2, 4
The NCCN advises against relying on staging systems alone - nomograms provide more personalized risk assessment for adjuvant treatment decisions 6